Biofrontera (BFRI) CFO Eugene Leffler Exercises RSUs

What Happened

• Eugene Leffler, Chief Financial Officer of Biofrontera Inc. (BFRI), had a derivative conversion reported on 2026-07-28. The filing shows 31,250 shares acquired via exercise/conversion (code M) and a simultaneous disposal of 31,250 derivative shares at $0.00. No cash proceeds are reported for the disposed shares.
• This activity relates to previously granted restricted stock units (RSUs) rather than an open-market buy or sale. The filing does not report a market sale of shares; the disposal at $0.00 is consistent with routine internal settlement mechanics (see footnotes).

Key Details

• Transaction date: July 28, 2026. Filing date: July 29, 2026 (timely filing).
• Reported transactions: 31,250 shares acquired (conversion/exercise, code M); 31,250 shares disposed at $0.00 (derivative).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Relevant footnotes:
  • F1: Company elected to convert the RSUs into common stock on a one-for-one basis.
  • F2: The RSUs were originally granted 7/22/2025 (62,500 RSUs total), vesting in two equal yearly installments beginning 7/22/2026; vested RSUs may be settled in shares, cash, or a combination within 60 days.
  • F3: RSUs with different terms are not included.
• Transaction code: M (exercise or conversion of a derivative security).

Context

• This filing documents conversion/settlement of RSUs rather than an open-market purchase or sale. Filings often show a portion of vested shares converted and a portion withheld or surrendered for tax/settlement purposes; the $0.00 disposal here fits that pattern rather than indicating a market sale.
• For retail investors, RSU vesting and conversion are routine compensation events and do not by themselves signal a change in insider sentiment about the stock.